Two Uofl professors provide reference works in oncology field

Two University of Louisville School of Medicine professors recently authored reference works in the field of oncology, one focusing on the use of radiation treatment for childhood cancers and the other on hepatocellular carcinoma, or liver cancer.

Dr. Edward C. Halperin, dean of the school, is co-author of the fifth edition of "Pediatric Radiation Oncology" and Dr. Kelly M. McMasters, chair of the Department of Surgery, is co-editor of a new work, "Hepatocellular Carcinoma: Targeted Therapy and Multidisciplinary Care."

Established since 1986 as the definitive text and reference on use of radiation therapy for childhood cancer, "Pediatric Radiation Oncology" reviews all significant recent clinical trials - including, for the first time, significant European clinical trials - and provides increased coverage of international and Third World issues. The latest cancer staging guidelines are included.

New chapters in the 512-page book cover psychosocial aspects of radiotherapy for the child and family and medical management of pain, nausea, nutritional problems and blood count depression in the child with cancer. A companion web site includes the full text and an image bank.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Rare genetic mutations in healthy women may be key to breast cancer origins